Last reviewed · How we verify

A Randomized, Double-blind, Placebo- & Positive-Controlled, Parallel Group, Dose Escalating Study to Evaluate the Effect of Buprenorphine Delivered by Buprenorphine Transdermal System at 10- and 40-mg Dose Levels on QT Intervals in Healthy Adult Volunteers

NCT01148537 Phase 1 COMPLETED Results posted

The purpose of this study is to examine the effect of buprenorphine on QT interval corrected for heart rate (QTc) in healthy subjects.

Details

Lead sponsorPurdue Pharma LP
PhasePhase 1
StatusCOMPLETED
Enrolment132
Start date2004-07
Completion2004-12

Conditions

Interventions

Primary outcomes

Countries

United States